Choice of anticoagulant can influence the analysis using fluorescence in situ hybridization of fetal cells enriched from maternal blood

Citation
V. Brombacher et al., Choice of anticoagulant can influence the analysis using fluorescence in situ hybridization of fetal cells enriched from maternal blood, PRENAT DIAG, 20(3), 2000, pp. 257-259
Citations number
13
Categorie Soggetti
Reproductive Medicine","Medical Research Diagnosis & Treatment
Journal title
PRENATAL DIAGNOSIS
ISSN journal
01973851 → ACNP
Volume
20
Issue
3
Year of publication
2000
Pages
257 - 259
Database
ISI
SICI code
0197-3851(200003)20:3<257:COACIT>2.0.ZU;2-G
Abstract
A notable degree of research attention is being focused on the use of fetal cells enriched from the blood of pregnant women as a non-invasive means of prenatal diagnosis. By using magnetic activated cells sorting (MACS) and f luorescence in situ hybridization (FISH), we have examined the efficacy of enriched fetal cells in determining fetal sex. An unexpected finding of thi s investigation was that the sensitivity of this analysis was influenced by the anticoagulant used to treat the maternal blood samples. As such, sampl es treated with heparin showed significantly lower detection rates than sam ples chelated with EDTA. Copyright (C) 2000 John Wiley & Sons, Ltd.